Filing Details

Accession Number:
0001209191-21-071268
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-27 16:42:59
Reporting Period:
2021-12-10
Accepted Time:
2021-12-27 16:42:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1634379 Metacrine Inc. MTCR Pharmaceutical Preparations (2834) 472297384
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1746342 Carmen Chang 2855 Sand Hill Road
Menlo Park CA 94025
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-12-10 37,570 $1.32 3,022,957 No 4 S Indirect See Note 1
Common Stock Disposition 2021-12-22 288,768 $1.00 2,734,189 No 4 S Indirect See Note 1
Common Stock Disposition 2021-12-22 170,932 $0.91 2,563,257 No 4 S Indirect See Note 1
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Note 1
No 4 S Indirect See Note 1
No 4 S Indirect See Note 1
Footnotes
  1. The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 16 securities in which the Reporting Person has no pecuniary interest.